| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.6M | -78.5% |
| R&D Expense | $135.0M | -21.8% |
| SG&A Expense | $74.2M | -8.9% |
| Operating Income | -$210.3M | -10.4% |
| Income Tax | $0 | — |
| Net Income | -$186.3M | -15.7% |
| EPS (Basic) | -$1.64 | +0.0% |
| EPS (Diluted) | -$1.64 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.1M | -13.9% |
| Short-term Investments | $243.0M | -11.1% |
| Accounts Receivable | $3.5M | +93.8% |
| Current Assets | $291.9M | -12.0% |
| Total Assets | $440.7M | -12.9% |
| Current Liabilities | $38.5M | -1.5% |
| Stockholders' Equity | $318.7M | -13.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$122.9M | +7.1% |
| Capital Expenditures | $730K | -88.1% |
| Investing Cash Flow | $12.2M | -89.2% |
| Financing Cash Flow | $99.9M | — |
| Free Cash Flow | -$123.6M | +10.7% |